Posts by camerontucker
Cord Blood CD34+ Cells: High Viability for Humanized Mouse Models
By: Joanna Wirkus The Rise of Cord Blood CD34+ Cells in Humanized Mouse Models and Cell Therapy Innovation Scientists in the late 1980’s discovered that umbilical cord blood derived stem cells had high proliferative potential and tolerated cryopreservation and thawing (Broxmeyer, 1989). Building on this research, the first report of cord blood derived CD34+ human…
For More InformationBuffy Coat vs. Leukapheresis: Choosing the Right Cell Source for Your Research
By: Joanna Wirkus Choosing Between Buffy Coat and Leukapheresis: A Guide for Scientists When your research hinges on high-quality, primary immune cells, starting with the right biological material can make or break your experiment. One of the most common questions we hear from scientists is: Should I use buffy coat- or leukapheresis-derived cells? The answer…
For More InformationCryopreservation in Cell and Gene Therapy: Ensuring High-Viability Cells for Research & Manufacturing
By Joanna Wirkus The Role of Cryopreservation in Cell and Gene Therapy Cryopreservation is a cornerstone of cell and gene therapy, enabling the long-term storage and viability of vital cell types such as CD34+ hematopoietic stem cells, mesenchymal stem cells (MSCs), natural killer (NK) cells, and T cells used in CAR-T therapies. Interestingly, nature has…
For More InformationCellsExpress: Affordable, Bulk Isolated Bone Marrow-Derived Stem Cells That Accelerate Your Cell and Gene Therapy Research
By Joanna Wirkus Bulk Bone Marrow Stem Cells for Research | CGT Global The race to develop life-saving cell and gene therapies is intensifying. Amid shifting political pressures, uncertain funding landscapes, and rising inflation, scientists are being asked to do more with less. Time, money, and labor must be optimized at every step—and that starts…
For More Information